July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Early Structural and Functional Abnormalities in Leber Congenital Amaurosis Caused by Mutations in RDH12
Author Affiliations & Notes
  • Tomas S Aleman
    Department of Ophthalmology, Scheie Eye Institute, Philadelphia, Pennsylvania, United States
  • Katherine E Uyhazi
    Department of Ophthalmology, Scheie Eye Institute, Philadelphia, Pennsylvania, United States
  • Leona Serrano
    Department of Ophthalmology, Scheie Eye Institute, Philadelphia, Pennsylvania, United States
  • Scott J Bowman
    Department of Ophthalmology, Scheie Eye Institute, Philadelphia, Pennsylvania, United States
  • Denise J Pearson
    Department of Ophthalmology, Scheie Eye Institute, Philadelphia, Pennsylvania, United States
  • Albert M Maguire
    Department of Ophthalmology, Scheie Eye Institute, Philadelphia, Pennsylvania, United States
  • Jean Bennett
    Department of Ophthalmology, Scheie Eye Institute, Philadelphia, Pennsylvania, United States
  • Footnotes
    Commercial Relationships   Tomas Aleman, None; Katherine Uyhazi, None; Leona Serrano, None; Scott Bowman, None; Denise Pearson, None; Albert Maguire, None; Jean Bennett, None
  • Footnotes
    Support  The Foundation Fighting Blindness, Hope for Vision,The Pennsylvania Lions Sight Conservation, the Brenda and Matthew Shapiro Stewardship, the Robert and Susan Heidenberg Investigative Research Fund for Ocular Gene Therapy, the RDH12 Fund for Sight
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 46. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Tomas S Aleman, Katherine E Uyhazi, Leona Serrano, Scott J Bowman, Denise J Pearson, Albert M Maguire, Jean Bennett; Early Structural and Functional Abnormalities in Leber Congenital Amaurosis Caused by Mutations in RDH12. Invest. Ophthalmol. Vis. Sci. 2018;59(9):46.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To describe the retinal structure and function of a relatively large group of pediatric patients with Leber congenital amaurosis (LCA) caused by mutations in the RDH12 gene.

Methods : Twenty patients from 13 families (ages 2-17 years) with RDH12-LCA underwent a complete ophthalmic exam. Imaging was performed with spectral domain optical coherence tomography (SD-OCT) and near infrared reflectance. Visual thresholds were measured with automated static perimetry and/or chromatic full-field sensitivity testing (FST) complemented by quantitation of the dark-adapted, chromatic, transient pupillary light reflex (TPLR).

Results : When measurable, visual acuity ranged from light-perception to 20/40. Early parafoveal depigmentation or atrophic maculopathies accompanied by midperipheral intraretinal pigment migration dominated the fundus appearance. SD-OCT showed early foveal thinning in all patients with detectable but thinned outer nuclear layer (ONL) at greater eccentricities from the fovea into the pericentral and peripapillary retina. Photoreceptor outer segment (POS) signals were only detectable in small pockets within the central retina. Measurable kinetic visual fields were limited to small (<5-10°) central islands of vision. Electroretinograms were reported as undetectable. FST sensitivities to a 467 nm stimulus were rod-mediated and reduced on average by ~2.5 log units. Thinned but detectable ONL in the central retina colocalized with severely reduced to non-detectable sensitivities. TPLR provided objective confirmation of the psychophysically measured abnormalities.

Conclusions : Early-onset, retina-wide disease with particularly severe central retinal abnormalities associated with detectable peripheral rod photoreceptor function in RDH12-LCA supports a pattern consistent with an early-onset cone-rod dystrophy. Severely abnormal POS but detectable ONL in the pericentral and peripapillary retina suggests these regions may be the targets for gene augmentation as a therapy for this condition.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×